Skip to content

The evaluation of the application of anesthesia depth monitoring based on EEG wavelet algorithm in target-controlled infusion anesthesia with propofol and remifentanile

The evaluation of the application of anesthesia depth monitoring based on EEG wavelet algorithm in target-controlled infusion anesthesia with propofol and remifentanil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091614
Enrollment
Unknown
Registered
2024-10-31
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Gold Standard:The reference standard for sedation level: bispectral index (BIS)
The reference standard for analgesia level: surgical pleth index (SPI) and pupillary dilatation (PD).
Index test:The experimental indicators are wavelet index (WLi) and pain threshold index (PTI) obtained by anesthesia depth monitoring based on the EEG wavelet algorithm.

Sponsors

The Second Affiliated Hospital of Naval Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Adult patients (aged 18~75 years) undergoing non-cardiac elective surgeries under target-controlled infusion intravenous anesthesia with propofol-remifentanil in each center.; 2. The subject meets the American Society of Anesthesiologists physical health status classification: Class I - Class II 3. 18.5 kg/m² = BMI < 30 kg/m²; 4. After fully explaining the study and with the subject fully understanding, sign a written informed consent form; 5. The subject's surgical position requires the patient to be supine.

Exclusion criteria

Exclusion criteria: 1. Central nervous system diseases and mental disorders; 2. Taking sedative or antidepressant drugs; 3. Communication difficulties (e.g. language difficulties, severe visual or hearing impairments); 4. Severe cardiopulmonary and cerebrovascular diseases, pacemaker implantation, bradycardia, uncontrolled hypertension [SBP > 180 mmHg and/or DBP > 100 mmHg at rest]; 5. Disorders of ocular muscles, neuromuscular system or pain perception; 6. Allergic to the drugs in this trial, pregnant women, difficult airway; 7. Expected operation duration > 3 hours; 8. Actual operation duration > 3 hours; 9. Participated in other clinical studies within 3 months; 10. The researcher believes that the subject is not suitable for participating in this clinical study due to other reasons.

Design outcomes

Primary

MeasureTime frame
intraclass correlation coefficient ;The area under the receiver operating characteristic curve (PTI/SPI/PD;

Secondary

MeasureTime frame
The average difference ;The standard deviation of difference ;The 95% Limits of Agreement;The proportion outside the consistency range ;sensitivity (PTI/SPI/PD);specificity (PTI/SPI/PD);The Youden Index (PTI/SPI/PD);The Prediction probabilities (PTI/SPI/PD) ;Pearson correlation coefficient (BIS/WLi);

Countries

China

Contacts

Public ContactFu Hailong

The Second Affiliated Hospital of Naval Military Medical University

fuhailong1979@163.com+86 135 8576 0822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026